Gene: FAM104B
Official Full Name: VCP nuclear cofactor family member 2provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23674 | FAM104B Knockout cell line (HeLa) | Human | FAM104B | 1:3~1:6 | Negative | Online Inquiry |
KO23675 | FAM104B Knockout cell line (HCT 116) | Human | FAM104B | 1:2~1:4 | Negative | Online Inquiry |
KO23676 | FAM104B Knockout cell line (HEK293) | Human | FAM104B | 1:3~1:6 | Negative | Online Inquiry |
KO23677 | FAM104B Knockout cell line (A549) | Human | FAM104B | 1:3~1:4 | Negative | Online Inquiry |
FAM104B Gene Knockout Cell Lines are specialized cellular models engineered to eliminate the expression of the FAM104B gene, a process achieved through advanced genome editing techniques such as CRISPR-Cas9. These knockout cell lines serve as vital tools for studying the functional roles of FAM104B in various biological processes, such as cell proliferation, differentiation, and responses to cellular stress. By selectively knocking out this gene, researchers can investigate the pathways and mechanisms that may be influenced by its absence, providing insights into its impact on cellular behavior and disease mechanisms.
The primary function of FAM104B Gene Knockout Cell Lines lies in their ability to facilitate the analysis of gene function in a controlled environment. When FAM104B is knocked out, researchers can effectively assess phenotypic changes and molecular alterations, shedding light on its contributions to cellular homeostasis and potential links to pathological conditions, including cancer and metabolic disorders. This capability is crucial for drug discovery efforts and identifying potential therapeutic targets.
Scientifically, the applications of these knockout cell lines extend to basic research, translational medicine, and the development of novel therapeutic approaches. In clinical settings, understanding the role of FAM104B can provide a basis for patient stratification in precision medicine, guiding tailored treatment strategies based on gene expression profiles.
Compared to other models, such as overexpression systems or wild-type cell lines, the FAM104B Gene Knockout Cell Lines offer a more nuanced approach to understanding gene function by directly observing the consequences of gene deletion. This specificity allows for clearer interpretations of experimental results, making these cell lines invaluable for researchers focused on gene regulation and signaling pathways.
For researchers and clinicians alike, the availability of FAM104B Gene Knockout Cell Lines represents a significant advancement in the pursuit of targeted therapies and deeper scientific understanding of gene functions. Our company is dedicated to providing high-quality biological products that empower researchers, and our expertise in genetic engineering ensures that your studies are backed by meticulously validated models designed for exceptional performance and reliability.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.